Saeid Ghavami to Cytochrome P-450 CYP3A Inhibitors
This is a "connection" page, showing publications Saeid Ghavami has written about Cytochrome P-450 CYP3A Inhibitors.
Connection Strength
0.046
-
FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy. Drug Resist Updat. 2020 12; 53:100719.
Score: 0.046
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.